{"id":"W3208513157","doi":"10.1016/j.jtocrr.2021.100251","title":"Concurrent Chemoradiation With or Without Durvalumab in Elderly Patients With Unresectable Stage III NSCLC: Safety and Efficacy","year":2021,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Takeda Canada; Bristol-Myers Squibb Canada; EMD Serono; Amgen; Boehringer Ingelheim; Meso Scale Diagnostics; Sanofi; Roche; GlaxoSmithKline; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Durvalumab; Medicine; Internal medicine; Hazard ratio; Stage (stratigraphy); Adverse effect; Incidence (geometry); Chemotherapy; Oncology; Cancer; Confidence interval; Immunotherapy","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002708682,0.0001418103,0.0005029877,0.00009458458,0.0001372262,0.00006884186,0.00003764871,0.0001292994,0.0001710436],"category_scores_gemma":[0.0008534254,0.00007929781,0.00004231643,0.0004729102,0.0005188463,0.0001026063,0.00007321029,0.0005723323,9.20918e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008094485,"about_ca_system_score_gemma":0.0009963036,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005024871,"about_ca_topic_score_gemma":0.001086486,"domain_scores_codex":[0.9971527,0.0002436325,0.0006860493,0.0005765918,0.0009751911,0.0003657925],"domain_scores_gemma":[0.9982521,0.0004427393,0.0001499175,0.0003333836,0.0005507672,0.0002711149],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01997223,0.0008863476,0.8310066,0.0001533959,0.0001332855,0.001337009,0.0001875529,8.85912e-7,0.00007688558,0.000006127575,0.0002756107,0.145964],"study_design_scores_gemma":[0.02304659,0.004411474,0.9397065,0.0006366442,0.00003464828,0.0001879064,0.0002595759,0.00007805228,0.0002256545,0.000006549565,0.0312394,0.0001669898],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996147,0.0007948557,0.00001846521,0.0009373893,0.00009140647,0.0008517486,0.000005918805,0.00001742625,0.001135829],"genre_scores_gemma":[0.9928088,0.001403367,0.0001036459,0.0001174867,0.000083007,0.0000240998,0.0000481139,0.00001916772,0.00539227],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.145797,"threshold_uncertainty_score":0.3233671,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0722457016137158,"score_gpt":0.4211569068315087,"score_spread":0.348911205217793,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}